Remdesivir disrupts COVID-19 virus better than other similar drugs

In the treatment of SARS-CoV-2, the virus that causes COVID-19, antiviral drug remdesivir has emerged as a promising candidate. Remdesivir works by disrupting the virus’s ability to replicate, but its exact mechanism has remained a mystery. Using advanced computational simulations, researchers at the Pritzker School of Molecular Engineering (PME) at the University of Chicago have…

Details

App will help visually impaired, seniors enjoy ride-sharing with self-driving cars

Self-driving cars will offer access to ride-sharing and ride-hailing with their suite of modern conveniences. However, many people with visual impairments who use these services rely on a human driver to safely locate their vehicle. A research group led by the Virtual Environments and Multimodal Interaction Laboratory (VEMI Lab) at the University of Maine is…

Details

Medicaid expansion in New York has improved maternal health, study finds

January 29, 2021 — A study at Columbia University Mailman School of Public Health and Columbia University Irving Medical Center has found that Medicaid expansion in 2014 in New York State was associated with a statistically significant reduction in severe maternal morbidity in low-income women during delivery hospitalizations compared with high-income women. The decrease was…

Details